Early detection of pancreatic cancer in the era of precision medicine
- PMID: 38761272
- DOI: 10.1007/s00261-024-04358-w
Early detection of pancreatic cancer in the era of precision medicine
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related mortality and it is often diagnosed at advanced stages due to non-specific clinical presentation. Disease detection at localized disease stage followed by surgical resection remains the only potentially curative treatment. In this era of precision medicine, a multifaceted approach to early detection of PDAC includes targeted screening in high-risk populations, serum biomarkers and "liquid biopsies", and artificial intelligence augmented tumor detection from radiologic examinations. In this review, we will review these emerging techniques in the early detection of PDAC.
Keywords: Artificial intelligence; CT; Cancer screening; Liquid biopsy; MRI; Pancreatic ductal adenocarcinoma.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer - a comprehensive review.J Exp Clin Cancer Res. 2024 Sep 2;43(1):250. doi: 10.1186/s13046-024-03166-w. J Exp Clin Cancer Res. 2024. PMID: 39218911 Free PMC article. Review.
-
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.Abdom Radiol (NY). 2020 Mar;45(3):729-742. doi: 10.1007/s00261-019-02290-y. Abdom Radiol (NY). 2020. PMID: 31768594 Review.
-
Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer.Semin Cancer Biol. 2025 Jun;111:76-88. doi: 10.1016/j.semcancer.2025.02.009. Epub 2025 Feb 20. Semin Cancer Biol. 2025. PMID: 39986585 Review.
-
Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer.BMC Cancer. 2025 Apr 23;25(1):762. doi: 10.1186/s12885-025-14124-w. BMC Cancer. 2025. PMID: 40269781 Free PMC article.
-
Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.Cancer Biomark. 2022;33(2):211-217. doi: 10.3233/CBM-210273. Cancer Biomark. 2022. PMID: 35213359 Free PMC article.
References
-
- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians. 2024;74(1):12–49. https://doi.org/10.3322/caac.21820 .
-
- Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Network Open. 2021;4(4):e214708. doi: https://doi.org/10.1001/jamanetworkopen.2021.4708 . - DOI - PubMed - PMC
-
- Cancer of the Pancreas - Cancer Stat Facts. SEER. https://seer.cancer.gov/statfacts/html/pancreas.html . Accessed September 30, 2023.
-
- Hackert T, Klaiber U, Pausch T, Mihaljevic AL, Büchler MW. Fifty Years of Surgery for Pancreatic Cancer. Pancreas. 2020;49(8):1005–1013. doi: https://doi.org/10.1097/MPA.0000000000001634 . - DOI - PubMed
-
- Takikawa T, Kikuta K, Hamada S, et al. Clinical features and prognostic impact of asymptomatic pancreatic cancer. Sci Rep. 2022;12:4262. doi: https://doi.org/10.1038/s41598-022-08083-6 . - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical